Pradaxa is a Oral Pellet in the Human Prescription Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is Dabigatran Etexilate Mesylate.
Product ID | 0597-0450_435b5f18-05cd-4a0b-9627-5aec67b79974 |
NDC | 0597-0450 |
Product Type | Human Prescription Drug |
Proprietary Name | Pradaxa |
Generic Name | Dabigatran Etexilate Mesylate |
Dosage Form | Pellet |
Route of Administration | ORAL |
Marketing Start Date | 2022-02-01 |
Marketing Category | NDA / |
Application Number | NDA214358 |
Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. |
Substance Name | DABIGATRAN ETEXILATE MESYLATE |
Active Ingredient Strength | 150 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2022-02-01 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0597-0108 | Pradaxa | dabigatran etexilate mesylate |
0597-0135 | Pradaxa | dabigatran etexilate mesylate |
0597-0149 | Pradaxa | dabigatran etexilate mesylate |
0597-0355 | Pradaxa | dabigatran etexilate mesylate |
0597-0360 | Pradaxa | dabigatran etexilate mesylate |
0597-0425 | Pradaxa | DABIGATRAN ETEXILATE MESYLATE |
0597-0430 | Pradaxa | DABIGATRAN ETEXILATE MESYLATE |
0597-0435 | Pradaxa | DABIGATRAN ETEXILATE MESYLATE |
0597-0440 | Pradaxa | DABIGATRAN ETEXILATE MESYLATE |
0597-0445 | Pradaxa | DABIGATRAN ETEXILATE MESYLATE |
0597-0450 | Pradaxa | DABIGATRAN ETEXILATE MESYLATE |
21695-899 | PRADAXA | dabigatran etexilate mesylate |
50090-3617 | Pradaxa | dabigatran etexilate mesylate |
50090-4480 | Pradaxa | dabigatran etexilate mesylate |
63629-8242 | Pradaxa | Pradaxa |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PRADAXA 85133694 3977066 Live/Registered |
Boehringer Ingelheim Pharma GmbH & Co.,KG 2010-09-20 |
PRADAXA 79193638 5173798 Live/Registered |
Boehringer Ingelheim Pharma GmbH & Co KG 2016-04-06 |
PRADAXA 79064548 3661185 Dead/Cancelled |
Boehringer Ingelheim Pharma GmbH & Co. KG 2008-10-29 |
PRADAXA 78282869 2874805 Live/Registered |
Boehringer Ingelheim Pharma GmbH & Co. KG 2003-08-04 |